More Articles
Historical Tidbit: Graves’ disease….or is it? Submitted by Evan Graber, DO In 1835 an Irish physician Sir Robert Graves first reported 4 women with “violent and long continued palpitations” and…
Read MoreIt is with sadness that we share the news of the passing of the founder of Degnon Associates, George K. Degnon, CAE. In 1979, he and his wife, Marge, started…
Read MoreMichelle Meder, MD I have recently started my third year of pediatric endocrinology fellowship at the University of Utah. I was raised in the St. Louis, Missouri area. I attended…
Read MoreHistorical Tidbit: Early evidence of psychosocial effects on growth -Frederick II (13th century Emperor of the Holy Roman Empire and King of Italy and Germany) Submitted by Alan D. Rogol,…
Read MoreNew Meds and Tech from PES Drugs and Therapeutics committee In June 2022, the Food and Drug Administration (FDA) approved a supplemental indication for Qsymia (phentermine and topiramate extended-release capsules)…
Read MoreNew Meds and Tech from PES Drugs and Therapeutics committee The FreeStyle Libre 3 is the third generation of Abbot Laboratories’ continuous glucose monitoring system intended for day-to-day glucose monitoring…
Read MoreNew Meds and Tech from PES Drugs and Therapeutics committee The Omnipod 5 (Insulet Inc) is a hybrid closed-loop system approved by the FDA on January 28, 2022 for use…
Read MoreHistorical Tidbit: A cautionary genetics tidbit Submitted by Walter L. Miller, MD Whole exome sequencing (WES) aims to determine the sequence of all protein-coding segments (‘exons’) in genomic DNA. As…
Read More